Publication | Closed Access

Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study

Confirmatory StudyOncologyPathologyBronchial NeoplasmCancer TreatmentCancer GeneticsMedicineRadiation OncologyLung Cancer